Corteva craters 22% after quarterly results miss estimates

Corteva (CTVA) shares fell 22% to $9.26 after Q3 results missed estimates, hitting a 52-week low of $9.18. The company reported non-GAAP EPS.

Original reporting
Published Nov 12, 2026, 3:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 3:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Corteva craters 22% after quarterly results miss estimates — source image
Decision brief

The 30-second read

$CTVABearishHigh
01

Why it matters

The earnings miss triggered a sharp intraday decline, indicating immediate negative sentiment.

02

Market read

The stock's 22% drop makes the news highly relevant for short‑term traders.

03

What to watch

Potential cost‑inflation pressures or supply‑chain issues not detailed in the brief.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Corteva (CTVA) is a U.S. agriscience company; the article is an AI‑generated summary of its Q3 earnings release.

Company-level read

Ticker impact

$CTVABearishHigh confidence
Context

Corteva reported Q3 results that missed estimates, causing the stock to plunge ~22% in morning trade.

Expected impact

downward pressure as investors price in weaker earnings

Evidence & confidence

The 22% drop reflects immediate market reaction to the miss; no mitigating news was provided.

Market effects

Agricultural chemicals sector may see broader weakness as earnings miss signals demand pressure.

U.S. agribusiness stocks could face short‑term downside.

Limited to sector; no broad macro impact.

Counterpoint

If the miss is viewed as a temporary setback, long‑term fundamentals may still support a rebound.

Key entities

  • Corteva, Inc.

    U.S. agriscience firm reporting Q3 results.

Related articles

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an

$CTVAMed

Mizuho reiterates Corteva stock rating on challenging crop market

Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.

$CTVAHighAI 8/10

Corteva shares fall 6% on worse-than-expected Q3 results

Corteva Inc. (CTVA) reported Q3 earnings of $0.06 per share, missing estimates of $0.10, and revenue of $1.59B, below the $1.77B forecast. Shares fell 6.4%. Full-year 2026 guidance adjusted, with EPS midpoint at $0.78, above consensus, but EBITDA guidance lowered due to Brazil market conditions. Revenue declined 9% YoY, with Latin America sales down 31% and North America up 7%.

$CTVAHighAI 8/10

Why is Corteva stock sliding today?

Corteva stock fell 6.4% after reporting Q3 results below expectations, with net sales down 9% YoY and a GAAP loss of $54M. Adjusted EPS dropped 57% to $0.06. The company cited weak Latin America performance and revised 2026 guidance lower, citing Brazil market conditions. Analysts had already cut EPS estimates and price targets. The S&P 500 was flat, indicating the drop was company-specific.